Analyst firms · BTIG · MGNX

BTIG MGNX price target and rating history

MacroGenics Inc. (MGNX) · Health Care

BTIG rates MacroGenics Inc. (MGNX) Neutral with a $24 price target, as of its latest action on Aug 1, 2024. It has published 3 rating actions on MGNX since October 2021, including 0 upgrades and 1 downgrade.

Current rating
Neutral
Price target
$24
Median target, all firms
Too few
Actions on MGNX
3

BTIG price target on MGNX

$50$37$2420222023202420252026
BTIG price target on MGNX, each point a stated target, October 2021 to March 2024.

Every BTIG rating on MGNX

Questions about BTIG and MGNX

What is BTIG's price target for MGNX?
BTIG's latest stated price target for MacroGenics Inc. (MGNX) is $24, from its action on Mar 4, 2024.
What is BTIG's rating on MGNX?
BTIG rates MGNX Neutral, a neutral rating, as of Aug 1, 2024.
When did BTIG last change its view on MGNX?
On Aug 1, 2024, BTIG downgrades to Neutral from Buy.

More MGNX rating histories

All BTIG ratingsMGNX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.